# GraftSource, LLC – FDA Inspection, Dec 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/graftsource-llc/fd275aa8-3402-4b0d-9bd0-50c32b90c458
Source feed: FDA_Inspections

> FDA inspection 1035434 of GraftSource, LLC, December 05, 2017. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035434
- Company Name: GraftSource, LLC
- Inspection Date: 2017-12-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1279228 - 2025-08-20
- FDA Inspection 1105852 - 2019-09-19
- FDA Inspection 865744 - 2014-02-06
- [FDA Inspection 762433 - 2012-01-11](https://www.keypedia.com/records/fda_inspections/graftsource-llc/62b500bc-9412-4898-81b1-7d5090a4bcd5)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)

Company: https://www.keypedia.com/companies/graftsource-llc/f4ba21be-1d0a-4ddf-b02b-a04ab713dead

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d